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The aim of this study was to screen the venom of the theraposid spider Avicularia juruensis
for the identification of antimicrobial peptides (AMPs) which could be further used as
prototypes for drug development. Eleven AMPs, named juruentoxins, with molecular
weight ranging from 3.5 to 4.5 kDa, were identified by mass spectrometry after the soluble
venom was separated by high performance liquid chromatography. Juruentoxins have
a putative inhibitory cystine knot (ICK) motif, generally found in neurotoxins, which are
also resistant to proteolysis. One juruentoxin that has 38 amino acid residues and three
disulfide bonds were characterized, to which we proposed the name Juruin. Based on
liquid growth inhibition assays, it has potent antifungal activity in the micromolar range.
Importantly, Juruin lacks haemolytic activity on human erythrocytes at the antimicrobial
concentrations. Based on the amino acid sequence, it is highly identical to the insecticidal
peptides from the theraposid spiders Selenocosmia huwena, Chilobrachys jingzhao, and
Haplopelma schmidti from China, indicating they belong to a group of conserved toxins
which are likely to inhibit voltage-gated ion channels. Juruin is a cationic AMP, and Lys22
and Lys23 show maximum positive charge localization that might be important for receptor
recognition. Although it shows marked sequence similarity to neurotoxic peptides, Juruin
is a novel exciting molecule with potent antifungal activity, which could be used as a novel
template for development of drugs against clinical resistant fungi strains.
Keywords: Juruin, juruentoxins, Avicularia juruensis, inhibitory cystine knot motif, Theraphosidae venom,
antimicrobial peptides
INTRODUCTION
While combinatorial libraries have been widely used for generat-
ing diverse synthetic chemical compounds (Martin et al., 1995;
Kirkpatrick et al., 1999), spider venom is a library with naturally
selected, biologically active peptides with high target specificity.
Therefore, spider toxins have been increasingly used as pharma-
cological tools and prototypes for drug development. From an
evolutionary perspective, spiders belong to a very ancient and
diversified group of arthropod with more than 40,700 described
species, distributed in approximately 109 families, which makes
them the most abundant terrestrial predators (Escoubas and
Rash, 2004; Herzig et al., 2011).
The molecular diversity of spider venom is estimated in over
12 million biological active peptides. These toxins show dif-
ferent biologically activities, some of which have evolved into
highly selective inhibitors of cell receptors (e.g., voltage-gated K+
ion channels) (Escoubas and Rash, 2004). The mix of several
types of cell proteins and toxin peptides may act synergistically
against their target, causing the venom noxious effects on its
prey (Herzig et al., 2011). Moreover, the structure, function, and
pharmacology of specific ion channels have been revealed by the
mechanism of action of several spider toxins. Additionally, toxins
binding selectivity and neuromodulatory effects could be used in
the treatment of neurodegenerative disorders, such as epilepsies,
Alzheimer and Parkinson’s disease (Estrada et al., 2007; Saez et al.,
2010). Advances over the past decades in mass spectrometry and
molecular biology methods have allowed the characterization of
genes related to such peptide toxins, which shed new light on the
molecular diversity and evolution of these living combinatorial
libraries (Corzo and Escoubas, 2003; Escoubas and King, 2009).
Spider toxins diversity is mainly based on small sized
disulphide-rich peptides, which are suggested to fall into a limited
number of structural patterns. Toxic peptides mainly conform
to the Inhibitory Cystine Knot (ICK) motif, with a disulfide
bond pairing of CI–CIV, CII–CV, CIII–CVI (Escoubas and Rash,
2004). It has been proposed that ICK toxins from spider venom
have evolved from β-defensin gene duplications, diversification
and further neofunctionalization (Fry et al., 2009). Defensins
are among the most widely distributed innate immunity–
related antimicrobial peptides (AMPs). In fact, cysteine-knotted
(ICK-related) structural dissection revealed a minimal struc-
ture with potent antimicrobial activity (Vila-Perelló et al., 2005),
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and even highly specific arachnid neurotoxins, which bind to
insect voltage-gated ion channels, have demonstrated antimicro-
bial activity (Redaelli et al., 2010). Convergently, Drosomycin,
a β-defensin that acts in the immune response of Drosophila
melanogaster, inhibits Na2+ channels in a manner similar to
those of scorpion neurotoxins (Cohen et al., 2009). Therefore,
the study of spider venom, a rich source of toxic peptides which
exhibit the ICK motif might reveal novel exciting prototypes for
antimicrobials design (Escoubas and Rash, 2004).
Accordingly to the ArachnoServer 2.0 <http://www.
arachnoserver.org/>, a database of toxic proteins from spi-
ders venom, 916 different peptides from 85 species have been
described so far (Herzig et al., 2011). Possible new peptides
and toxins have been revealed by the combination of mass
spectrometry and transcriptomic analysis, as well as screening
the venom for desired properties. However, knowledge about the
composition of the venom of many spider species remains very
poor (Diego-García et al., 2010).
Here, we started to investigate the venom of the arboreal
species Avicularia juruensis (Figure 1). TheAvicularia genus com-
prises 13 species, endemic from regions in Central and South
America, with at least three species threatened by habitat loss and
illegal trafficking (Bertani and Fukushima, 2009). The Amazonian
Pink Toe spider, Avicularia juruensis (Mello-Leitão, 1923), is a
tarantula considered as an extremely docile species and not toxic
to human being. Together with its stunning color and size, taran-
tulas from the Avicularia genus are one of the animals that are
most often chosen as exotic pets. Even though the Amazonian
Pink Toe spider is widely known, there are no studies available
about its venom composition. Hence, the aim of this work was
FIGURE 1 | Adult female Avicularia juruensis (Theraphosidae,
Mygalomorphae). Photo: Ayroza, G.
to explore the venom composition from A. juruensis, particularly
to search novel antimicrobial compounds. This study is to the
best of our knowledge the first venom analysis from the Brazilian
spider A. juruensis (Amazonian Pink Toe), which resulted in the
characterization of novel ICK toxins named juruentoxins.
MATERIALS ANDMETHODS
BACTERIAL STRAINS
Fungal and bacterial strains were obtained from various sources.
Escherichia coli SBS363 andMicrococcus luteusA270 were from the
Pasteur Institut, Paris; Candida albicans (MDM8) was from the
Department of Microbiology from the University of São Paulo,
Brazil; E. coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853,
Staphylococcus aureus ATCC 29213, and S. epidermidis ATCC
12228 were from the American Type Culture Collection (ATCC).
The following human clinical yeast isolates, which can be agents
of candidiasis disease, obtained from the Oswaldo Cruz Institute,
Brazil, were also used: Candida krusei IOC 4559, C. glabrata IOC
4565, C. albicans IOC 4558, C. parapsilosis IOC 4564, C. tropicalis
IOC 4560, and C. guilliermondii IOC 4557. The filamentous fungi
Aspergilus niger and the entomopathogenic fungus Beauveria
bassiana were isolated from a mummified spider.
ANIMALS
The spiders (Avicularia juruensis, a tarantula of the
Theraphosidae family) were kept alive in the biotherium of
the Center for Applied Toxinology, of the Butantan Institute (São
Paulo, Brazil) (Figure 1). These animals were collected under
license Permanent Zoological Material no.11024-3-IBAMA
and Special Authorization for Access to Genetic Patrimony
no.001/2008.
VENOM FRACTIONATION AND JURUIN ISOLATION
In short, adult spiders were electrically stimulated for venom.
A. juruensis crude venom was resuspended in 0.1% aqueous tri-
fluoroacetic acid containing 10% acetonitrile (CH3CN), and the
insoluble material was removed by centrifugation at 14,000×g
for 5min. The supernatant was used directly for HPLC separa-
tion. The diluted venom was fractionated using a reverse-phase
semipreparative C18 column (Jupiter, 10 × 250mm) equilibrated
in 0.05% trifluoroacetic acid and eluted with a linear gradient
from solution A [0.05% (v/v) trifluoroacetic acid in water] to
80% solution B [0.10% (v/v) trifluoroacetic acid in acetonitrile]
run for 60min at a flow rate of 1.5ml/min. Effluent absorbance
was monitored at 225 nm. Fraction with antimicrobial activity
(Juruin) was further purified using a distinct gradient from 30 to
40% solution B run for 60min in the same system. The purity
of the peptide was ascertained by a symmetrical peak on the
HPLC system, amino acid sequencing, and mass spectrometry
analysis.
REDUCTION AND ALKYLATION
Freeze-dried purified protein was dissolved (1mg/ml) in denatu-
rant buffer [6MGdmCl (guanidinium chloride), 0.25MTris/HCl
and 1mM EDTA, pH 8.5]. To the mixture, 20μl of 2- mer-
captoethanol (Sigma) was added, followed by vortex-mixing
and incubating at 37◦C for 2 h. After incubation, 100μl of
4-vinylpyridine was added to the solution, followed by incubation
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at room temperature (26◦C) for 2 h. It was then subjected to
RP-HPLC and the protein was eluted. The reduction and alky-
lation of the protein were confirmed by checking the mass
using MALDI-TOF-MS. The reduced and alkylated protein was
fragmented by enzymatic cleavage with trypsin (Boehringer
Mannhein). Tryptic peptides were sequenced using tandem mass
spectrometry (MS/MS) in a Q-TOF Ultima API (Micromass)
spectrometer operating in positive ion mode. The
deposited in UniProt (http://www.uniprot.org/) under accession
number B3EWQ0.
MASS SPECTROMETRIC ANALYSIS
The samples containing the peptide fragments (0.5μl) were spot-
ted onto the sample slide and dried on the bench and crystallized
with 0.5μl of matrix solution [5mg/ml (w/v) CHCA (α-cyano-
4-hydroxycinnamic acid), in 50% acetonitrile and 0.1% TFA]
(Sigma). The samples were analyzed on an EttanMALDI-ToF/Pro
spectrometer (Amershan Biosciences) operating in reflectron
mode. To determine the amino acid sequence of peptides, the
doubly charged ions were subjected to “de novo” sequencing in a
Q-TOF Ultima API (Micromass) spectrometer operating in pos-
itive ion mode. The spectrum was analyzed, and the “y” and “b”
fragments were used to elucidate the primary structure of the
molecule.
ANTIMICROBIAL ASSAYS
During the purification procedure, the antimicrobial activities of
the samples were monitored by liquid growth inhibition assays
using the Gram-negative bacteria Escherichia coli SBS363 and
Gram-positive bacteria Micrococcus luteus A270 that were cul-
tured in poor broth nutrient medium (PB: 1.0 g peptone in
100mL of water containing 86mM NaCl at pH 7.4; 217 mOsM),
whereas yeast strain Candida albicans MDM8 was cultured in
poor dextrose broth (1/2 PDB: 1.2 g potato dextrose in 100mL
of H2O at pH 5.0; 79 mOsM) used at half-strength as previsouly
described (Hetru and Bulet, 1997; Bulet, 2008). Determination
of antimicrobial activity was performed using 5-fold micro titer
broth dilution assay in 96-well sterile plates at a final volume of
100mL. Mid-log phase culture was diluted to a final concentra-
tion of 1 × 105 colony forming units/mL. Dried fractions were
dissolved in 200μL of ultrapure water and 20μL applied in to
each well and added to 80μL of the bacterium/yeast dilution.
The fractions were tested in duplicate. 100μL of sterile water
and PB or PDB were used as quality controls. Tetracycline and/or
Amphotericin B were also used as controls of growth inhibition.
The microtiter plates were incubated for 18 h at 30◦C; growth
inhibition was determined by measuring absorbance at 595 nm.
MICs DETERMINATION
The minimal inhibitory concentration was determined using the
purified peptide against the Gram-negative bacterial strains, the
Gram-positive bacterial strains, the fungal strains and the yeast
strains, as described above. The peptide was dissolved in sterile
water and peptide concentration was measured using the method
of Bradford (1976). Determination of minimal inhibitory con-
centrations (MICs) for Juruin was performed using a five-fold
microtiter broth dilution assay of stock solution, and serial dilu-
tion in 96-well sterile plates at a final volume of 100μL where
20μL of stock solution was applied in to each well at serial
dilution two-fold microtiter broth dilution and added to 80μL
of the bacterium/yeast dilution. Microbial growth was measured
by monitoring the increase in OD at 595 nm after incubation
at 30◦C for 18 h (modified from Ehret-Sabatier et al., 1996).
Juruin was tested in duplicate. MIC is defined as the minimal
concentration of peptide that caused 100% growth inhibitions
(Zhu et al., 2007). Juruin was incubated by 18 h with C. guil-
liermondii IOC 4555716, C. krusei IOC 4559, C. glabrata IOC
45658, C. tropicalis IOC 4560, and Aspergillus niger in order to
identify whether is fungicidal or fungistatic by growth recov-
ery (Baumann et al., 2010), using water, Amphotericin B and
Gomesin as controls.
HAEMOLYTIC ACTIVITY
The haemolytic activity of the protein was tested using human
erythrocytes. A 2.5% (v/v) suspension of washed erythrocytes in
PBS was incubated with Juruin ranging from 0.125 to 10μM in
a 96-well plate for 3 h with intermittent shaking. The absorbance
in the supernatant was measured at 415 nm. Haemolysis caused
by PBS and 1% (v/v) Triton X-100 were used as 0% and 100%
controls, respectively.
HOMOLOGYMODELING
Since Juruin shows more than 60% sequence similarity to U1-
theraphotoxin-Ba1a (PDB ID: 2KGH) from Brachypelma ruh-
naui, with all of the cysteine residues conserved when aligned
using Muscle (Edgar, 2004), U1-theraphotoxin-Ba1a structure,
determined by NMR (Corzo et al., 2009), was used as a template
for homology modeling. SWISS-MODEL (Arnold et al., 2006;
Kiefer et al., 2009), an automated protein modeling server (http://
www.expasy.ch/swissmod/SWISS-MODEL.html), was used to
obtain a preliminary three-dimensional structural model of
Juruin. However, three disulfide bonds were missing in themodel.
Disulfide bonds were incorporated using the Biopolymer mod-
ule from Insight II software (Accelrys). The model was sub-
jected to energy minimization using the steepest descent method
(100 steps) followed by the conjugate gradient method until
the RMSD (root mean square deviation) was 0.5 kcal/mol Å
(1 kcal ≈4.184 kJ). The resulting structure was checked for bond
length and bond angle consistency as well as peptide bond con-
formation. The quality of the final structure was evaluated using
a Ramachandran plot.
RESULTS
PURIFICATION AND PRIMARY STRUCTURE DETERMINATIONOF
JURUIN
The soluble venom of A. juruensis was separated in at least 35
different components by HPLC (Figure 2). The fraction eluted
at 40.0min, named Juruin, showed antimicrobial activity
against Candida albicans MDM8 and was further purified
until homogeneity as shown in the inset of Figure 2A. The
inset graphic shows the elution of a major component (the
peptide under study) plus some minor contaminants that
were discarded. We have idenfied other three antimicrobial
fractions, which eluted at 11.2, 40.6, and 42.0min (Figure 2),
respectively. All antimicrobial fractions were analyzed by mass
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FIGURE 2 | Purification and covalent structure of Juruin. (A) 2.5mg of
soluble venom from A. juruensis was separated by HPLC using a C18
reverse-phase column, eluted with a linear gradient from solution A to 80%
solution B run for 50min. The fractions labeled with the asterisk exhibited
antimicrobial activity and were eluted at 11.2, 40.6, and 42.0min,
respectively. The fraction labeled with an arrow was eluted at 40.0min, and
was rechromatographed in the same system and run from 30% to 40%
solution B in 60min (inset). The major component is pure Juruin.
(B) Complete amino acid sequence of Juruin was obtained by mass
spectrometry fragmentation of several peptides obtained by enzymatic
hydrolysis of Juruin, as indicated by the segments underlined by dotted
lines. Solid lines linking the cysteine residues indicate the disulfide bridges
in positions Cys3 to Cys24, Cys7 to Cys30, and Cys15 to Cys35. The
N-terminal phenylalanine and the C-terminal amidated valine were
determined by mass spectrometry (MS/MS) fragmentation.
spectrometry (Figure 3). Fraction eluting at 11.2min showed
two components with molecular weight of 4011.93 and 4033.16.
Fraction eluted at 40.6min showed the presence of six masses:
3506.86, 3599.07, 3629.692, 4004.47, 4252.50, 4319.79. Fraction
eluted at 42.0min showed the presence of more two components:
4252.30, 4319.94. Finally, analysis of Juruin showed the presence
of a single component with a molecular weight of 4005.83
(Figure 3B). Comparision of molecular masses to previously
identified spider toxins suggest these peptides contain an ICK
motif (Escoubas and Rash, 2004). Therefore, we proposed the
name juruentoxins for the peptides belonging to these group of
toxins from Avicularia juruensis venom. The componentes with
molecular masses: 4005.83, 4011.93, 4033.16, 3506.86, 3599.07,
3629.692, 4004.47, 4252.50, 4319.79, 4252.30, 4319.94 have
been named U-theraphotoxin-Aju1a, U-theraphotoxin-Aju2a,
U-theraphotoxin-Aju3a, U-theraphotoxin-AjuT4a, U-thera
photoxin-AjuT5a, U-theraphotoxin-AjuT6a, U-theraphotoxin-
AjuT7a, U-theraphotoxin-Aju8a, U-theraphotoxin-Aju9a,
U-theraphotoxin-Aju10a, and U-theraphotoxin-Aju11a, respec-
tively, accordingly to a previous proposed nomenclature (King
et al., 2008). Aju1a will be referred with the name Juruin, in
reference to the spider A. juruensis, as it is the first characterized
peptide from this species.
We determined the amino acid sequence of Juruin by MS/MS
fragmentation (Figure 4). Three main fragments were obtained
after enzymatic hydrolysis with trypsin, as indicated by the dot-
ted line under the sequence shown in Figure 2. The fragment
corresponding to the positions Phe1 to Lys10 was sequenced
(Figure 4A) and was further aligned with several peptides
obtained by enzymatic hydrolysis, after their mass fragmentation
(MS/MS) as indicated under the sequence of Figure 2. The second
fragment, corresponding to the positions between Phe1 to Lys23
was sequenced (Figure 4B), positioned and correctly aligned with
the previous subpeptide. The last segment, a subpeptide corre-
sponding to positions Cys24 to Lys37, was sequenced (Figure 4C)
and positioned correctly into the sequence as derived from the
results of overlapping sequences obtained by mass fragmenta-
tion, as indicated. This sequence was also confirmed through the
examination of another peptide, consisting of residues between
Cys24 and Lys31 (data not shown). The fact that the peptide from
position Phe1 to Lys37 presented a calculated molecular weight
of 3907.59 Da indicates there is a missing residue at C-terminus.
Considering a mass difference of 98.2 Da between the calcu-
lated mass to the mass observed by MALDI-TOF/MS suggest
a valine C-amidated. Confirmation of the sequence came from
the results of amino acid sequence comparison of Juruin against
91 known ICK containing peptides deposited at ArachnoServer
2.0 (Herzig et al., 2011). Whitin the Toxin-20 Family (Pfam
ID: PF08089), the identities fall higher than 70% against any
of the toxins considered. This high sequence similarity sug-
gested that Juruin contains a highly conserved scaffold whitin
spider toxins. In several toxins the scaffold compromises a C-
terminal amidated valine (Liang, 2004). Therefore, these results
suggest that Juruin has a amidated valine at the C-terminus.
Additionally, sequence allignement with 26 toxins demonstrates
equivalent folding of the disulfide bridges for Juruin, with disul-
fide pairing made between cysteines that occupy the same relative
position (Figure 5). The identification of disulfide bridges are as
follows: one between Cys3 and Cys24, the other between Cys7
and Cys30 and the third disulfide pairing formed by Cys16 to
Cys35. The theoretically expected and the experimentally found
molecular weights are similar (MW calculated: 4005.74, MW
observed: 4005.83; for reduced Juruin, MW calculated: 4008.2,
MW observed: 4007.8).
ANTIMICROBIAL ACTIVITY
Since many ICK toxins are reported to have antimicrobial
activity, we tested native Juruin for antimicrobial activity by
liquid growth inhibition assays for target pathogens, and com-
pared with Amphotericin B and Gomesin (Silva jr. et al., 2000).
Juruin showed high antimicrobial activity against all yeast and
filamentous fungi tested, except for Beauveria bassiana. The
MIC of Juruin against C. albicans was 2.5–5μM. The most
sensitive strains were Candida spp. Additionally, the filamen-
tous fungi tested Aspergilus niger was highly sensitive to Juruin
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FIGURE 3 | Mass spectroscopic analysis of peptides. (A–D) are the mass spectra of the peaks obtained by HPLC with retention times 11.2, 40.0, 40.6, and
42.0min, respectively. (B) Correspond to the observed mass of native Juruin (4005.83) and reduced Juruin (inset).
(MIC: 10μM). However, Juruin did not show any antibacterial
effect on the three Gram-positive strains tested, M. luteus, S. epi-
dermidis, and S. aureus, or on the Gram-negative strains E. coli
and P. aeruginosa, even at a concentration as high as 100μM.
Juruin showed similar antifungal activity to other host defense
cysteine-rich peptide, Gomesin. However, when compared to
Amphotericin B, the MICs are usually six fold lower than Juruin
(Table 1). WhenC. albicans andC. tropicaliswere incubated in the
presence of Juruin at 20μM for 16 h, a full growth recovery was
not observed, hinting at fungicidal rather than fungistatic activity.
HAEMOLYTIC ACTIVITY
To investigate whether Juruin has any effect onmammalianmem-
branes at the antimicrobial concentration range, its haemolytic
effect was tested. After incubating human erythrocytes with the
protein up to 10μM concentrations, no haemoglobin release was
observed, indicating that Juruin does not cause lysis of erythro-
cyte membrane within these concentrations (results not shown).
STRUCTURE-FUNCTION RELATIONSHIP STUDIES
Disulfide bridges are required for the highly compact, stabi-
lized folding of many cysteine-rich proteins and their biological
function, such as the antimicrobial properties of β-defensins
(Yenugu et al., 2003). Due to the lack of material, we could not
determine the importance of disulfide bonds and folding for
the antifungal properties of Juruin. Instead, a three-dimensional
model of Juruin was built using the known structure of U1-
theraphotoxin-Ba1a (PDB ID: 2KGH), from Brachypelma ruh-
naui (Corzo et al., 2009), since it shows 60% identity, with all of
the cysteine residues conserved. The homology model of Juruin
is shown in Figure 6. The final structure had ϕ and ψ angles
within the allowed region of the Ramachandran map and all
the peptide bonds were trans. A total of 15 residues (39.47%)
were in the fully allowed region, 11 residues (28.95%) were in
the additionally allowed region, nine residues (23.7%) were in
the generously allowed region and only three residues (7.9%)
were in the outside region. Juruin model shows similarity to
the structure of U1-theraphotoxin-Ba1a, consisting of an ICK
motif with three cross-linked disulfide bonds. The structure con-
sists of three antiparallel β-sheet at residues 14–16, 27–31, and
34–37. The remaining part of the molecule is loop-structured
(Figures 6A–C). The analysis of the electrostatic potential of the
molecule reveals that the charge distribution is distinct, in which
the middle segment of the molecule harbors maximum surface
positive charge (Figure 6F), which may be essential for antimi-
crobial activity (Yin et al., 2012). This region, between Cys16 to
Cys24 of Juruin, comprises three positively charged residues out
of nine residues (CKGSGEKKC).
DISCUSSIONS
The findings described in this study provide novel information
for the development of antimicrobial drugs. We have described
the isolation and the complete covalent structure determination
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FIGURE 4 | Mass spectrometry analysis of Juruin peptides.
(A) Collision-induced dissociation spectrum from mass/charge (m/z)
1211.3 generated by trypsin digestion after analysis by LC/MS, showing
the dominant fragment KIDCS with a m/z of 621.26, which corresponds
to an N-terminal segment. (B) Collision-induced dissociation spectrum
from m/z 2579.8, showing the b and y ion series that corresponds to
the partial sequencing of the tryptic peptide between residues Phe1 to
Lys30, which allowed the assignment of four cysteines, Cys3, Cys7,
Cys24, and Cys30, as well as the lysine rich region Lys22-Lys23.
(C) MS/MS spectrum from the precursor ion at m/z 1679.69 which
corresponds to the C-terminus of Juruin, lacking the amidated valine
at the end.
of Juruin. To our knowledge, this is the first peptide isolated
from A. juruensis, a mygalomorph spider which belongs to the
Theraphosidae family (Figure 1). When we analyzed the struc-
ture of Juruin in the context of what is known for the other
spider toxins (Escoubas and Rash, 2004; Kuhn-Nentwig et al.,
2004; Liang, 2004), it is clear that its structure is highly conserved.
However, we could identify six novel residues within a highly
conserved scaffold from an arboreal spider toxin (Figure 5C).
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FIGURE 5 | Amino acid sequence comparision of Juruin (Aju1a) to
other ICK-containing toxins. (A) Multiple sequence alignement of Juruin
to selected toxins. Amino acid sequences of toxins were retrieved from
public databases and aligned with Muscle (Egdar, 2004). Cysteines are in
yellow. To minimize confusion, all sequences are referred to by their
UniProt accession numbers (http://www.uniprot.org/). Juruin (B3EWQ0),
U3-theraphotoxin-Cj1a (B1P1A5), U3-theraphotoxin-Cj1a (B1P1A6),
U3-theraphotoxin-Cj1b (B1P1A8), U3-theraphotoxin-Cj1b (B1P1A7),
U3-theraphotoxin-Cj1c (B1P1A9) from Chilobrachys jingzhao.
U1-theraphotoxin-Ba1b (P85504), U1-theraphotoxin-Ba1a (P85497) from
Brachypelma ruhnaui. U1-theraphotoxin-Bs1a (P49265) from Brachypelma
smithi. U1-theraphotoxin-Asp1b (P61510), U1-theraphotoxin-Asp1a (P61509)
from Aphonopelma californicum. Putative mature sequence toxin-like RFEC
(D5J6X7), putative mature peptide toxin-like LFEC (D5J6X5) from Pelinobius
muticus. U1-theraphotoxin-Lp1b (P61506) from Lasiodora parahybana.
Hainantoxin-II-17 (D2Y2D4), Hainantoxin-II-15 (D2Y226) from Haplopelma
hainanum. Huwentoxin-7 (P68421), U1-theraphotoxin-Hh1a (P82959),
HWTX-VIII (B5U1K0), HWTX-II (B3FIU5), HWTX-VIIIa (B3FIT5), HWTX-IIb
(B3FIS9), HWTX-IIa (B3FIS8), U1-theraphotoxin-Hh1f (P68422),
Huwentoxin-2a (Q86C49), HWTX-VIIb (B3FIT3), HWTX-VIIa (B3FIT2) from
Haplopelma schimidti. (B) Amino acid occurrence within selected toxins.
(C) Structural similarity of Juruin to that of U3-theraphotoxin-Cj1a, from
Chilobrachys jingzhao, to which Juruin shares 80% sequence similiarity.
Conserved residues are shown in black boxes.
We suggest that these residues might have been positively selected
during evolution, which can cause an increase in the binding
affinity to its target receptor.
Firstly, we have screened the venom of A. juruensis,
monitoring the antimicrobial activity using liquid growth
inhibition assays. Out of more than 40 fractions, we have
identified only four fractions which exhibited toxicity to
tested microorganisms (Figure 2). Mass spectrometric analy-
sis revealed the masses of 11 compounds: 4005.83, 4011.93,
4033.16, 3506.86, 3599.07, 3629.692, 4004.47, 4252.50,
4319.79, 4252.30, 4319.94 (Figure 3), which have been named
U-theraphotoxin-Aju1a, U-theraphotoxin-Aju2a, U-thera
photoxin-Aju3a, U-theraphotoxin-AjuT4a, U-theraphotoxin-
AjuT5a, U-theraphotoxin-AjuT6a, U-theraphotoxin-AjuT7a,
U-theraphotoxin-Aju8a, U-theraphotoxin-Aju9a, U-thera
photoxin-Aju10a, and U-theraphotoxin-Aju11a, respectively,
accordingly to a previous proposed nomenclature (King et al.,
2008). Aju1a will be referred with the name Juruin, in reference
to the spider A. juruensis, as it is the first characterized peptide
from this species.
When compared to other known toxins from spiders, these
compounds shows similarity to ICK-containing peptides, with
molecular masses ranging from 3.0 kDa to 7.5 kDa (Escoubas and
Rash, 2004). ICK-containing peptides in spider venom seem to
have evolved from β-defensins, while they have gained novel func-
tions during evolutionary recruitment events (Fry et al., 2009).
Therefore, even highly specific neurotoxins have been shown to
exhibit a high antimicrobial activity (Kuhn-Nentwig, 2003), and
also antimicrobial compounds at spider venoms act in syner-
gism to neurotoxins (Kuhn-Nentwig et al., 2004). In this work,
we investigated the antimicrobial properties from the compound
with 4,005.83 Da, named Juruin, which has been purified to
homogeneity (Figure 2). Further research will focus on those
other compounds.
Juruin is a 38-residue peptide with three disulphide bridges
conformed in an ICK motif, and a valine amidated at the
C-terminus, similarly to previous identified huwentoxins from
Selenocosmia (Ornithoctonus) huwena (Liang, 2004). The disul-
fide bridges and C-terminal amidation certainly contributes to
the stability of the peptide to proteases within the venom or when
it is released for defense or against a prey (Silva jr. et al., 2000).
Juruin is a highly cationic AMP, with seven positively charged
residues (seven Lys) with a calculated pI of 9.08. Our struc-
tural model and sequence allignment suggest that the six cysteine
residues in Juruin form three disulfide bridges linking Cys3-Cys24
(CI-CIV), Cys7-Cys30 (CII-CV), and Cys16-Cys35 (CIII-CVI),
such disulphide array is identical for all ICK-containing toxins
from spiders (Escoubas and Rash, 2004). Interestingly, in Juruin
an equal number of residues is observed between disulfide bridges
as it is observed among other ICK-containing toxins (Figure 5A).
Sequence comparison between Juruin to U3-theraphotoxin-Cj1a,
from Chilobrachys jingzhao, to which Juruin shares 80% sequence
similarity, reveals the difference of only six residues (Figure 5C).
It has more than 70% of sequence similarity to Toxin-20 family
(Pfam ID: PF08089) of peptides, from the spiders Ornithoctonus
huwena (Liang, 2004; Yuan et al., 2007; Jiang et al., 2010),
Chilobrachys jingzhao (Liao et al., 2007; Chen et al., 2008) and
Haplopelma hainanum from China (Pan and Yu, 2010; Tang et al.,
2010), which are neurotoxins with broad biological activities,
including: voltage-gated ion channels inhibition, bioinsectici-
dal activity and inhibition of trypsin (Liang, 2004). While the
three residues between Cys3-Cys7 (Ala4, Ile5, Ser6) have already
been identified in the putative mature sequence toxin-like RFEC
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Table 1 | Antimicrobial activities of cysteine-rich antimicrobial peptides against selected microorganisms.
MIC [µM (µg/mL)] Juruin Gomesin Amphotericin B
GRAM-POSITIVE BACTERIA
Micrococcus luteus A270 ND 0.4 (0.88) ND
Staphylococcus aureus ATCC 29213 ND 1.2 (2.6) ND
Staphylococcus epidermidis ATCC12228 ND NT ND
GRAM-NEGATIVE BACTERIA
Escherichia coli SBS363 ND 0.4 (0.88) ND
Escherichia coli ATCC 25922 ND 0.9 (1.9) ND
Pseudomonas aeruginosa ATCC 27853 ND 5 (11) ND
FILAMENTOUS FUNGI
Beauveria bassiana ND NT 0.07-0.15 (0.06-0.13)
Aspergilus niger 5–10 (20–40) 1.2 (2.6) 0.01–0.03 (0.01–0.03)
YEAST
Candida albicans MDM8 2.5–5 (10–20) 1.25–2.5 (2.7–5.5) 0.01–0.03 (0.01–0.03)
Candida krusei IOC 4559 2.5–5 (10–20) 2.5–5 (5.5–11) 0.07–0.15 (0.06–0.13)
Candida glabrata IOC 45658 2.5–5 (10–20) >10 (22) ND
Candida albicans IOC 45588 2.5–5 (10–20) 5–10 (11–22) ND
Candida parapsilosis IOC 456416 2.5–5 (10–20) 2.5–5 (5.5–11) 0.07–0.15 (0.06–0.13)
Candida tropicalis IOC 45608 2.5–5 (10–20) 0.3–0.6 (0.6–1.2) 0.07–0.15 (0.06–0.13)
Candida guilliermondii IOC 455716 2.5–5 (10–20) 2.5–5 (5.5–11) 0.07–0.15 (0.06–0.13)
The activity of Juruin was compared to Gomesin (Silva jr. et al., 2000) and Amphotericin B. MIC values (µM) refer to the minimal inhibitory concentration required
toachieve 100% growth inhibition. ND, not detected in the ranges assayed; NT, not tested.
(Uniprot ID: D5J6X7) from Pelinobius muticus, Thr2, Val11, Ser29,
Phe32, and Val34 are novel residues within this toxin scaffold.
When compared to more than 91 toxins, none of them presents
those residues at these positions. It is likely that these amino acids
residues are important to bioactivity of Juruin, being positively
selected during evolution, instead of having appeared from neu-
tral mutations. Surprisingly, Juruin is the unique Toxin-20 Family
belonging peptide which has a Thr2 at the N-terminal region. In
contrast to all species producing Toxin-20 family proteins, which
are burrowing tarantulas, A. juruensis is an arboreal spider from
the Amazonian rainforest also known as bird eating tarantula,
because it often prey small vertebrates such as birds, small lizards,
and tree frogs. Therefore, higher toxicity against vertebrates as
well as unusual activities in the venom of an arboreal species
could have appeared from divergent sequence patterns and pos-
itive Darwinian selection. The Brazilian insular arboreal pitviper
Bothorps insularis (Cogo et al., 1998) show variation on the snake
venom composition as well as divergent sequence patterns which
might be the result of a significant dietary habit change and
positive Darwinian selection causing an increase in venom toxi-
city. Therefore, Juruin should be included in further phylogenetic
analyses with other ICK containing toxic peptides.
Juruin is effective against the majority of the fungi and
yeast strains tested, with MICs between 2.5–5μM for all of
them, except for Aspergilus niger which showed MIC between
5–10μM. Although cysteine-rich AMPs play an important role
on spider immune system and often show a broad spectrum
of activity against pathogens (Silva jr. et al., 2000), Juruin,
a highly knotted cysteine-rich AMP, didn’t show antibacte-
rial activity against Gram-positive and Gram-negative bacte-
ria tested. Also, antifungal activity against B. bassiana could
FIGURE 6 | Homology modeling of Juruin. Comparison of Juruin and
U1-theraphotoxin-Ba1a (PDB ID: 2KGH), from Brachypelma ruhnaui,
structures. (A,B) Juruin (blue) and U1-theraphotoxin-Ba1a (green) ribbon
structures were superimposed over the backbone atoms. (C) Ribbon
structure of Juruin in a different view related by ∼90◦ rotation. (D,E)
Molecular surface of Juruin highlighted to show electrostatic potential,
surfaces with positive, negative, and neutral electrostatic potentials are
drawn in blue, red, and white, respectively. (F) The Lys22-Lys23 segment
shows maximum positive charge localization represented by the intense
blue color. Model pairs show the sides of the protein rotated by ∼180◦.
not be observed. Juruin has marked activity against a vari-
ety of yeast at a rather low concentration, the most resis-
tant strain being the yeast C. glabrata (Table 1). Interestingly,
Juruin has similar MICs to that of Gomesin, a potent host
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defense peptide previously identified by our group (Silva jr.
et al., 2000). Amidated Gomesin has a slightly more pronounced
active antimicrobial effect when compared to that of non-
amidated form. The lack of disulphide pattern in Gomesin after
reduction/alkylation produce a decrease in antimicrobial activ-
ity. Similarly, disulphide bridge pattern and post-translational
modification might be related to antimicrobial activity and a
putative neurotoxic effect of Juruin. However, Amphotericin B
is effective even in six-fold lower concentrations (μM) than
that of Juruin. On the other hand, Juruin is effective against
Amphotericin B-resistant strains, C. albicans IOC 45588 and the
clinically important C. glabrata (Krogh-Madsen et al., 2006; Khan
et al., 2008).
We tested the toxicity to human erythrocytes only within the
antimicrobial ranges. Juruin do not show haemolytic activity even
at the higher concentration tested 10μM. This data suggests that
the mode of action of Juruin is not by disrupting cell membranes.
Moreover, the presence of a large number of positively charged
amino acids in host defense peptides contributes to a higher speci-
ficity of the peptide to a higher electronegative charged targets,
such as prokaryotic cells (Silva jr. et al., 2000), nucleic acids or
intracellular proteins (Nguyen et al., 2011). Therefore, the pos-
itively charged residues (Figure 6) might be involved in target
receptor recognition and selectivity against pathogens and preys.
The specific antimicrobial activity of Juruin against fungi and
yeast gives novel evidences for the origin of arachnid toxins
from antifungal β-defensins (Zhu et al., 2005). After one or sev-
eral recruitment events, defensins sequence duplication and wide
divergence driven by positive Darwinian selection might have
expanded this class of molecules into new functional groups (Fry
et al., 2009), probably including ICK-containing toxins. The evi-
dence of positive Darwinian selection in the ICK fold within
spider toxins suggests that adaptive amino acid changes in a
conserved scaffold are a major force driving new functional emer-
gence. Therefore, divergent sequence patterns should be used for
peptide-based drug design (Zhu et al., 2005, 2011). Hence, the
identification of novel residues within a highly conserved scaffold
offers a potential to investigate the divergent evolution of A. juru-
ensis toxins, and Juruin is a natural template for development of
novel therapeutical drugs.
In summary, we have isolated, purified and characterized a
new ICK-containing AMP, named Juruin (Aju1a). The remark-
able similarity to other toxins with other interesting bioactivities
such as ion channels modulations (Liang, 2004) and antipara-
sitic activity (Pimentel et al., 2006), the highly conserved primary
structure of the toxin, along with its selectivity, potent fungici-
dal activity, and the lack of haemolytic activity against human
erythrocytes together with a putative resistance against pro-
teases, makes Juruin pharmacologically interesting and valuable
for the design of novel efficient drugs against fungal diseases.
Thus, Juruin unique sequence should be investigated as a novel
prototype for drug development.
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